
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $15.4M | $17.8M | $11.1M | $8.3M | $16.3M | |
Selling, General & Admin | $14.9M | $14.5M | $10.8M | $9.2M | $8.7M | |
Other Inc / (Exp) | -$2.2M | -$45.3M | -$18.7M | -$3M | $23.4M | |
Operating Expenses | $30.3M | $32.3M | $21.9M | $17.5M | $25M | |
Operating Income | -$30.3M | -$32.3M | -$21.9M | -$17.5M | -$25M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$32.6M | -$77.6M | -$40.6M | -$20.3M | -$1.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -$10M | -$1.4M | -- | -$6K | |
Net Income to Company | -$32.6M | -$67.6M | -$39.2M | -$20.3M | -$1.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$32.6M | -$67.6M | -$39.2M | -$20.3M | -$1.8M | |
Basic EPS (Cont. Ops) | -$86,611.70 | -$107,700.64 | -$45,696.97 | -$3,045.78 | -$5,217.50 | |
Diluted EPS (Cont. Ops) | -$86,611.70 | -$107,700.64 | -$45,696.97 | -$3,045.78 | -$5,217.50 | |
Weighted Average Basic Share | $380 | $630 | $860 | $6.7K | $1.1K | |
Weighted Average Diluted Share | $380 | $630 | $860 | $6.7K | $1.1K | |
EBITDA | -$32.3M | -$77.3M | -$40M | -$20.2M | -$1.5M | |
EBIT | -$32.4M | -$77.5M | -$40.5M | -$20.2M | -$1.6M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$30.3M | -$32.3M | -$21.9M | -$17.5M | -$25M | |
Operating Income (Adjusted) | -$32.4M | -$77.5M | -$40.5M | -$20.2M | -$1.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.4M | $5.3M | $1.4M | $2.3M | $2.3M | |
Selling, General & Admin | $4.7M | $3M | $2.3M | $2.2M | $1.8M | |
Other Inc / (Exp) | $109K | $218K | -$436K | $14.7M | $58K | |
Operating Expenses | $9.1M | $8.3M | $3.7M | $4.4M | $4.1M | |
Operating Income | -$9.1M | -$8.3M | -$3.7M | -$4.4M | -$4.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$9M | -$8.1M | -$4.1M | $10.3M | -$4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $114K | -- | |
Net Income to Company | -$9M | -$8.1M | -$4.1M | $10.2M | -$4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9M | -$8.1M | -$4.1M | $10.2M | -$4M | |
Basic EPS (Cont. Ops) | -$15,370.50 | -$12,859.18 | -$4,070.30 | $1,099.37 | -$4.63 | |
Diluted EPS (Cont. Ops) | -$15,370.50 | -$12,859.18 | -$77,085.00 | $1,099.37 | -$4.63 | |
Weighted Average Basic Share | $580 | $630 | $1K | $9.3K | $1.1M | |
Weighted Average Diluted Share | $580 | $630 | $1K | $9.3K | $1.1M | |
EBITDA | -$8.9M | -$7.6M | -$4.1M | $10.4M | -$4M | |
EBIT | -$8.9M | -$8.1M | -$4.1M | $10.3M | -$4M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$9.1M | -$8.3M | -$3.7M | -$4.4M | -$4.1M | |
Operating Income (Adjusted) | -$8.9M | -$8.1M | -$4.1M | $10.3M | -$4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $16.3M | $18.7M | $7.2M | $9.2M | $16.3M | |
Selling, General & Admin | $16.4M | $12.8M | $10.1M | $9.1M | $8.4M | |
Other Inc / (Exp) | -$2.3M | -$45.2M | -$19.4M | $12.1M | $8.7M | |
Operating Expenses | $32.7M | $31.5M | $17.3M | $18.2M | $24.7M | |
Operating Income | -$32.7M | -$31.5M | -$17.3M | -$18.2M | -$24.7M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$35M | -$76.8M | -$36.6M | -$5.8M | -$16.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $114K | -$120K | |
Net Income to Company | -$35M | -$66.8M | -$35.2M | -$6M | -$16.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$35M | -$66.8M | -$35.2M | -$6M | -$16.1M | |
Basic EPS (Cont. Ops) | -$84,740.48 | -$110,576.56 | -$47,504.46 | -$1,921.27 | -$1,261.36 | |
Diluted EPS (Cont. Ops) | -$84,740.48 | -$110,576.56 | -$120,932.13 | -$1,921.27 | -$1,261.36 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$34.7M | -$76.1M | -$36.4M | -$5.4M | -$15.6M | |
EBIT | -$34.9M | -$76.7M | -$36.5M | -$5.8M | -$15.9M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$32.7M | -$31.5M | -$17.3M | -$18.2M | -$24.7M | |
Operating Income (Adjusted) | -$34.9M | -$76.7M | -$36.5M | -$5.8M | -$15.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $4.4M | $5.3M | $1.4M | $2.3M | $2.3M | |
Selling, General & Admin | $4.7M | $3M | $2.3M | $2.2M | $1.8M | |
Other Inc / (Exp) | $109K | $218K | -$436K | $14.7M | $58K | |
Operating Expenses | $9.1M | $8.3M | $3.7M | $4.4M | $4.1M | |
Operating Income | -$9.1M | -$8.3M | -$3.7M | -$4.4M | -$4.1M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$9M | -$8.1M | -$4.1M | $10.3M | -$4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $114K | -- | |
Net Income to Company | -$9M | -$8.1M | -$4.1M | $10.2M | -$4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9M | -$8.1M | -$4.1M | $10.2M | -$4M | |
Basic EPS (Cont. Ops) | -$15,370.50 | -$12,859.18 | -$4,070.30 | $1,099.37 | -$4.63 | |
Diluted EPS (Cont. Ops) | -$15,370.50 | -$12,859.18 | -$77,085.00 | $1,099.37 | -$4.63 | |
Weighted Average Basic Share | $580 | $630 | $1K | $9.3K | $1.1M | |
Weighted Average Diluted Share | $580 | $630 | $1K | $9.3K | $1.1M | |
EBITDA | -$8.9M | -$7.6M | -$4.1M | $10.4M | -$4M | |
EBIT | -$8.9M | -$8.1M | -$4.1M | $10.3M | -$4M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$9.1M | -$8.3M | -$3.7M | -$4.4M | -$4.1M | |
Operating Income (Adjusted) | -$8.9M | -$8.1M | -$4.1M | $10.3M | -$4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $16.9M | $22.3M | $6.2M | $4.3M | $1.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $1.2M | $1.1M | $1.2M | $1.1M | $795K | |
Total Current Assets | $18.1M | $23.5M | $7.4M | $5.4M | $2.6M | |
Property Plant And Equipment | $1.8M | $3.4M | $2.1M | $1.6M | $1.2M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $15.7M | $15.7M | $3.1M | -- | -- | |
Other Intangibles | $77.1M | $32.1M | $25.3M | $25.3M | $24.1M | |
Other Long-Term Assets | $154K | $154K | $154K | $150K | $9K | |
Total Assets | $112.9M | $74.8M | $38M | $32.4M | $27.9M | |
Accounts Payable | $1.2M | $693K | $249K | $809K | $1.9M | |
Accrued Expenses | $3.8M | $3.4M | $1.6M | $1.6M | $1.4M | |
Current Portion Of Long-Term Debt | $352K | $294K | $252K | $233K | $333K | |
Current Portion Of Capital Lease Obligations | $805K | $528K | $404K | $436K | $508K | |
Other Current Liabilities | -- | -- | -- | $900K | $963K | |
Total Current Liabilities | $6.1M | $4.9M | $2.5M | $4M | $5.7M | |
Long-Term Debt | $2.4M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $43.3M | $32.9M | $27.9M | $29M | $17.9M | |
Common Stock | $17K | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $69.6M | $41.9M | $10M | $3.4M | $10M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $69.6M | $41.9M | $10M | $3.4M | $10M | |
Total Liabilities and Equity | $112.9M | $74.8M | $38M | $32.4M | $27.9M | |
Cash and Short Terms | $16.9M | $22.3M | $6.2M | $4.3M | $1.8M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $38.5M | $15.5M | $4.2M | $2.5M | $1.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $851K | $906K | $987K | $792K | $421K | |
Total Current Assets | $39.3M | $16.4M | $5.2M | $3.3M | $1.6M | |
Property Plant And Equipment | $3.6M | $2.8M | $2M | $1.5M | $1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $15.7M | $15.7M | $2.6M | -- | -- | |
Other Intangibles | $77.1M | $32.1M | $25.3M | $25.3M | $24.1M | |
Other Long-Term Assets | $154K | $154K | $163K | $9K | $9K | |
Total Assets | $135.9M | $67.1M | $35.2M | $30.1M | $26.8M | |
Accounts Payable | $939K | $724K | $753K | $1.7M | $3.1M | |
Accrued Expenses | $3.7M | $3.6M | $1.6M | $2.1M | $1.8M | |
Current Portion Of Long-Term Debt | $2.4M | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $392K | $472K | $389K | $446K | $519K | |
Other Current Liabilities | -- | -- | -- | $725K | $521K | |
Total Current Liabilities | $7.5M | $4.8M | $2.8M | $5M | $6.5M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $44.4M | $32.4M | $28.2M | $14.7M | $16.5M | |
Common Stock | $26K | $28K | $1K | $1K | $4K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -$483K | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $91.5M | $34.7M | $7M | $15.4M | $10.3M | |
Total Liabilities and Equity | $135.9M | $67.1M | $35.2M | $30.1M | $26.8M | |
Cash and Short Terms | $38.5M | $15.5M | $4.2M | $2.5M | $1.2M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$32.6M | -$67.6M | -$39.2M | -$20.3M | -$1.8M | |
Depreciation & Amoritzation | $168K | $192K | $533K | $82K | $84K | |
Stock-Based Compensation | $5.7M | $7.2M | $3.1M | $1.3M | $455K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$25.3M | -$23.7M | -$19.5M | -$13.4M | -$15.4M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$291K | -$279K | $197K | -$15K | -$12K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$657K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $547K | -- | -- | -- | $1.9M | |
Long-Term Debt Repaid | -$3.8M | -$3.9M | -$1.2M | -$797K | -$605K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$1.9M | |
Other Financing Activities | $2.8M | $1M | -- | -- | $8.5M | |
Cash From Financing | $20M | $29.4M | $3.1M | $11.6M | $12.7M | |
Beginning Cash (CF) | $22.7M | $17.1M | $22.5M | $6.3M | $4.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$5.6M | $5.4M | -$16.2M | -$1.9M | -$2.7M | |
Ending Cash (CF) | $17.1M | $22.5M | $6.3M | $4.5M | $1.8M | |
Levered Free Cash Flow | -$25.6M | -$23.9M | -$19.5M | -$13.5M | -$15.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9M | -$8.1M | -$4.1M | $10.2M | -$4M | |
Depreciation & Amoritzation | $45K | $466K | $23K | $21K | $17K | |
Stock-Based Compensation | $2.4M | $770K | $285K | $251K | $72K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$6M | -$6.7M | -$2.5M | -$2.9M | -$2.4M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$3K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$90K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $250K | |
Long-Term Debt Repaid | -$352K | -$294K | -$252K | -$233K | -$166K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$483K | |
Other Financing Activities | -- | -- | -- | -$100K | $2M | |
Cash From Financing | $27.6M | -$89K | $591K | $1M | $1.8M | |
Beginning Cash (CF) | $17.1M | $22.5M | $6.3M | $4.5M | $1.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $21.6M | -$6.8M | -$1.9M | -$1.9M | -$606K | |
Ending Cash (CF) | $38.6M | $15.7M | $4.4M | $2.6M | $1.2M | |
Levered Free Cash Flow | -$6M | -$6.7M | -$2.5M | -$2.9M | -$2.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$35M | -$66.8M | -$35.2M | -$6M | -$16.1M | |
Depreciation & Amoritzation | $171K | $613K | $90K | $80K | $80K | |
Stock-Based Compensation | $6.4M | $5.6M | $2.6M | $1.2M | $276K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$25.9M | -$24.3M | -$15.3M | -$13.9M | -$14.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$291K | -$282K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$747K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $2.1M | |
Long-Term Debt Repaid | -$3.9M | -$3.8M | -$1.1M | -$778K | -$538K | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | $10.6M | |
Cash From Financing | $47.8M | $1.7M | $3.8M | $12M | $13.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $21.6M | -$22.9M | -$11.3M | -$1.8M | -$1.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$26.2M | -$24.6M | -$15.3M | -$13.9M | -$14.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9M | -$8.1M | -$4.1M | $10.2M | -$4M | |
Depreciation & Amoritzation | $45K | $466K | $23K | $21K | $17K | |
Stock-Based Compensation | $2.4M | $770K | $285K | $251K | $72K | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$6M | -$6.7M | -$2.5M | -$2.9M | -$2.4M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$3K | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -$90K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | $250K | |
Long-Term Debt Repaid | -$352K | -$294K | -$252K | -$233K | -$166K | |
Repurchase of Common Stock | -- | -- | -- | -- | -$483K | |
Other Financing Activities | -- | -- | -- | -$100K | $2M | |
Cash From Financing | $27.6M | -$89K | $591K | $1M | $1.8M | |
Beginning Cash (CF) | $17.1M | $22.5M | $6.3M | $4.5M | $1.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $21.6M | -$6.8M | -$1.9M | -$1.9M | -$606K | |
Ending Cash (CF) | $38.6M | $15.7M | $4.4M | $2.6M | $1.2M | |
Levered Free Cash Flow | -$6M | -$6.7M | -$2.5M | -$2.9M | -$2.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.